R T Chen

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies
    Robert T Chen
    Immunization Safety Branch, National Immunization Program MS E61 Centers for Disease Control, Prevention Corporate Square Office Park, Building 12 Rm 2419 CDC, Atlanta, GA 30333, USA
    Vaccine 22:2047-53. 2004
  2. ncbi Epidemiology of autoimmune reactions induced by vaccination
    R T Chen
    Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Autoimmun 16:309-18. 2001
  3. ncbi Combination vaccines: postlicensure safety evaluation
    R T Chen
    Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:S327-33. 2001
  4. ncbi Myocarditis: the unexpected return of smallpox vaccine adverse events
    Robert T Chen
    Immunization Safety Branch, National Immunization Program, and Smallpox Eradication Program Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 362:1345-6. 2003
  5. ncbi Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team
    U D Parashar
    Epidemic Intelligence Service, Viral Gastroenteritis Section, CDC, Atlanta, GA 30333, USA
    Pediatr Infect Dis J 17:605-11. 1998
  6. ncbi Challenges and controversies in immunization safety
    R T Chen
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Infect Dis Clin North Am 15:21-39, viii. 2001
  7. ncbi Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team
    P Kramarz
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Fam Med 9:617-23. 2000
  8. ncbi Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team
    P Kramarz
    Centers for Disease Control and Prevention, 1600 Clifton Road, MS E61, Atlanta, GA 30333, USA
    Vaccine 18:2288-94. 2000
  9. ncbi Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus
    F DeStefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3724, USA
    Pediatrics 108:E112. 2001
  10. ncbi Addressing the challenges to immunization practice with an economic algorithm for vaccine selection
    B G Weniger
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 16:1885-97. 1998

Detail Information

Publications68

  1. ncbi Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies
    Robert T Chen
    Immunization Safety Branch, National Immunization Program MS E61 Centers for Disease Control, Prevention Corporate Square Office Park, Building 12 Rm 2419 CDC, Atlanta, GA 30333, USA
    Vaccine 22:2047-53. 2004
    ..The new clinical immunization safety assessment centers may play an important role in bridging the sometimes conflicting clinical and epidemiologic perspectives in vaccine safety...
  2. ncbi Epidemiology of autoimmune reactions induced by vaccination
    R T Chen
    Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Autoimmun 16:309-18. 2001
    ..Examples include the possible association of immunization and multiple sclerosis (and other demyelinating diseases), type 1 diabetes mellitus, Guillain-Barre Syndrome, idiopathic thrombocytopenic purpura, and rheumatoid arthritis...
  3. ncbi Combination vaccines: postlicensure safety evaluation
    R T Chen
    Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:S327-33. 2001
    ..Only by investing in vaccine safety infrastructure at a level commensurate with investments in vaccine development can we hope to retain the public's confidence in immunization...
  4. ncbi Myocarditis: the unexpected return of smallpox vaccine adverse events
    Robert T Chen
    Immunization Safety Branch, National Immunization Program, and Smallpox Eradication Program Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 362:1345-6. 2003
  5. ncbi Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team
    U D Parashar
    Epidemic Intelligence Service, Viral Gastroenteritis Section, CDC, Atlanta, GA 30333, USA
    Pediatr Infect Dis J 17:605-11. 1998
    ..We used information from the Vaccine Safety Datalink (VSD) about approximately 1 million children enrolled in four health maintenance organizations to assess the morbidity from diarrhea and estimate the disease burden of rotavirus...
  6. ncbi Challenges and controversies in immunization safety
    R T Chen
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Infect Dis Clin North Am 15:21-39, viii. 2001
    ..It also provides information on how various safety research is conducted, some of the concurrent challenges, and finally, some guidance on communicating with patients on vaccine risks...
  7. ncbi Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team
    P Kramarz
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Fam Med 9:617-23. 2000
    ..One reason for low influenza vaccine coverage among children with asthma may be concern that influenza vaccination may induce an exacerbation of asthma...
  8. ncbi Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team
    P Kramarz
    Centers for Disease Control and Prevention, 1600 Clifton Road, MS E61, Atlanta, GA 30333, USA
    Vaccine 18:2288-94. 2000
    ..Vaccination coverage could be increased by taking advantage of all opportunities to vaccinate children with asthma whenever they make clinic visits in the fall and early winter...
  9. ncbi Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus
    F DeStefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3724, USA
    Pediatrics 108:E112. 2001
    ..To evaluate suggested associations between childhood vaccinations, particularly against hepatitis B and Haemophilus influenzae type b, and risk of developing type 1 diabetes; and to determine whether timing of vaccination influences risk...
  10. ncbi Addressing the challenges to immunization practice with an economic algorithm for vaccine selection
    B G Weniger
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 16:1885-97. 1998
    ....
  11. ncbi The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA
    R T Chen
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Bull World Health Organ 78:186-94. 2000
    ....
  12. ncbi Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union
    R T Chen
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 181:S178-83. 2000
    ..It is concluded that initial priority for scarce resources for controlling this outbreak should be placed on vaccination of persons susceptible to diphtheria (e.g., adults) rather than revaccination of children...
  13. ncbi Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination
    T Verstraeten
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Epidemiol 154:1006-12. 2001
    ..7 and 4.4, respectively) were comparable with those reported in the two studies. Linkage of VAERS to complimentary data sources may permit more timely postmarketing assessment of vaccine safety...
  14. ncbi The incidence of Kawasaki syndrome in West Coast health maintenance organizations
    E D Belay
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 19:828-32. 2000
    ..Kawasaki syndrome (KS) causes an acute vasculitis of unknown etiology. It is a leading cause of acquired heart disease of children in Japan and the United States...
  15. ncbi A 'post-honeymoon period' measles outbreak in Muyinga sector, Burundi
    R T Chen
    National Immunization Program MS E61 Centers for Disease Control and Prevention, Atlanta, GA 30333
    Int J Epidemiol 23:185-93. 1994
    ..Such outbreaks present new challenges to newly maturing immunization programmes in improving skills in surveillance, outbreak investigation, and public relations...
  16. ncbi Does influenza vaccination prevent asthma exacerbations in children?
    P Kramarz
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Pediatr 138:306-10. 2001
    ..The effectiveness of influenza vaccine in preventing influenza-related asthma exacerbations, however, is not known. We evaluated influenza vaccine effectiveness in protecting children against influenza-related asthma exacerbations...
  17. ncbi Individual and community risks of measles and pertussis associated with personal exemptions to immunization
    D R Feikin
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C23, Atlanta, GA 30333, USA
    JAMA 284:3145-50. 2000
    ..The risk of vaccine-preventable diseases among children who have philosophical and religious exemptions from immunization has been understudied...
  18. ncbi An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group
    J A Singleton
    Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 17:2908-17. 1999
    ..The acceptability, sensitivity and representativeness of VAERS are unknown. The study of vaccine safety is complicated by underreporting, erroneous reporting, frequent multiple exposures and multiple outcomes...
  19. ncbi The National Immunization Information Hotline
    D A Gust
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Health Commun 9:371-9. 2004
    ....
  20. ncbi National Immunization Information Hotline: Calls concerning adverse events, 1998-2000
    D A Gust
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgi 30333, USA
    J Health Commun 9:387-94. 2004
    ....
  21. ncbi Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases
    Thomas Verstraeten
    Epidemic Intelligence Service Program, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 112:1039-48. 2003
    ..Conflicting results were found at different HMOs for certain outcomes. For resolving the conflicting findings, studies with uniform neurodevelopmental assessments of children with a range of cumulative thimerosal exposures are needed...
  22. ncbi An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Penina Haber
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 113:e353-9. 2004
    ....
  23. ncbi Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa
    Donatus U Ekwueme
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Bull World Health Organ 80:859-70. 2002
    ..To investigate and compare seven types of injection devices for their risks of iatrogenic transmission of bloodborne pathogens and their economic costs in sub-Saharan Africa...
  24. ncbi Guillain-Barré syndrome following influenza vaccination
    Penina Haber
    Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 292:2478-81. 2004
    ..Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990...
  25. ncbi Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program
    James Baggs
    Centers for Disease Control and Prevention, National Immunization Program, Epidemiology and Surveillance Division, Immunization Safety Branch, 1600 Clifton Rd, Mailstop E61, Atlanta, GA 30333, USA
    Clin Infect Dis 40:1133-40. 2005
    ..This report describes the frequency of such symptoms among 936 adult smallpox vaccinees with and without a history of prior smallpox vaccination...
  26. ncbi Active surveillance of vaccine safety: a system to detect early signs of adverse events
    Robert L Davis
    Departments of Epidemiology and Pediatrics, University of Washington, Seattle, Washington, USA
    Epidemiology 16:336-41. 2005
    ..To evaluate the feasibility of developing such systems, we used 5 years of data from 4 health maintenance organizations within the Centers for Disease Control and Prevention (CDC) Vaccine Safety Datalink...
  27. ncbi Promise of new Japanese encephalitis vaccines
    Marc Fischer
    National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521, USA
    Lancet 370:1806-8. 2007
  28. ncbi Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003
    Armenak Asatryan
    Science Applications International Corporation and Emory University School of Medicine, Atlanta, GA, USA
    Vaccine 26:1166-72. 2008
    ..Thus, HL following MMCV has been reported in the literature and to the VAERS. Further studies are needed to better understand if there is a causal relationship between MMCV and HL...
  29. ncbi A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004
    Louisa E Chapman
    Epidemiology and Surveillance Division, National Immunization Program, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 46:S271-93. 2008
    ..This review of sentinel cases augmented the ongoing safety review process and was transparent, but it shares limitations with other case-based causality-assessment methods...
  30. ncbi HIV testing outside of the study among men who have sex with men participating in an HIV vaccine efficacy trial
    Deborah A Gust
    National Center for HIV AIDS, Viral Hepatitis, TB and STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 52:294-8. 2009
    ....
  31. ncbi Hepatitis B vaccine and risk of multiple sclerosis
    Frank Destefano
    Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3724, USA
    Expert Rev Vaccines 1:461-6. 2002
    ..The US Institute of Medicine and other review panels have concluded that the evidence favors rejection of a causal association between hepatitis B vaccine and multiple sclerosis...
  32. ncbi Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial
    Deborah A Gust
    HIV Vaccine and Special Studies Team, Epidemiology Branch, Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 24:1135-43. 2010
    ..Determine whether male circumcision would be effective in reducing HIV transmission among men who have sex with men (MSM)...
  33. ncbi Vaccinations and risk of central nervous system demyelinating diseases in adults
    Frank Destefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Neurol 60:504-9. 2003
    ..Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases...
  34. ncbi Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States
    Vitali Pool
    Vaccine Safety and Development Activity, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:e71. 2002
    ....
  35. ncbi Vaccine risks: real, perceived and unknown
    R T Chen
    Vaccine Safety and Development Branch, National Immunization Program MS E61, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    Vaccine 17:S41-6. 1999
    ....
  36. ncbi Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine
    W A Wattigney
    Centers for Disease Control and Prevention, National Immunization Program, Atlanta, Georgia 30341 3717, USA
    Pediatrics 107:E83. 2001
    ..We compared VAERS reports after the receipt of IPV to reports after OPV in infants from 1991 through 1998. Comparisons included reports listing IPV and OPV coadministered with other vaccines...
  37. ncbi Processes for obtaining nonmedical exemptions to state immunization laws
    J S Rota
    Centers for Disease Control and Prevention, Measles Virus Section, Mail Stop C 22, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Am J Public Health 91:645-8. 2001
    ..This study sought to determine the specific processes required for obtaining religious and philosophical exemptions to school immunization laws...
  38. ncbi A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001
    Weigong Zhou
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 13:505-10. 2004
    ..A population-based controlled study is needed to determine whether this association could be causal and to quantify the risk...
  39. ncbi Childhood vaccinations and risk of asthma
    Frank Destefano
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 21:498-504. 2002
    ..The weak associations for Hib and hepatitis B vaccines seem to be at least partially accounted for by health care utilization or information bias...
  40. ncbi Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients
    Arnulfo A Muralles
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 24:476-84. 2006
    ..5%), muscle pain (23.1%), chills (14.4%), joint pain 11.8%, and fever >100 degrees F (12.5%). The 12.5% reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration...
  41. ncbi Population-based study of rotavirus vaccination and intussusception
    P Kramarz
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 20:410-6. 2001
    ..0. The attributable risk was one case of intussusception per 11 073 children vaccinated. CONCLUSIONS: RRV-TV is associated with an increased risk of intussusception. The risk is greatest 3 to 7 days after the first vaccination dose...
  42. ncbi Autism and measles-mumps-rubella vaccination: controversy laid to rest?
    F DeStefano
    National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia 30341 3724, USA
    CNS Drugs 15:831-7. 2001
    ..Currently, the weight of the available epidemiological and related evidence does not support a causal association between MMR vaccine, or any other vaccine or vaccine constituent, and autism...
  43. ncbi Principles of measles control
    F T Cutts
    Immunization Division, Centers for Disease Control, Atlanta, GA 30333
    Bull World Health Organ 69:1-7. 1991
    ....
  44. ncbi A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination
    Thomas Verstraeten
    Epidemic Intelligence Service Program, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 112:e98-103. 2003
    ..We assessed the association of varicella breakthrough with asthma, steroids, age at varicella vaccination, and timing of measles-mumps-rubella (MMR) vaccination...
  45. ncbi Advanced age a risk factor for illness temporally associated with yellow fever vaccination
    M Martin
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:945-51. 2001
    ..For elderly travelers, the risk for severe illness and death due to YF infection should be balanced against the risk for systemic illness due to YF vaccine...
  46. ncbi The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety
    John K Iskander
    Centers for Disease Control and Prevention, National Immunization Program, Epidemiology and Surveillance Division, Immunization Safety Branch, Atlanta, GA 30333, USA
    Pediatr Ann 33:599-606. 2004
    ..This process begins with voluntary submission of reports of possible vaccine-associated events to VAERS by the informed and conscientious health professional...
  47. ncbi Adverse event reports following vaccination for Lyme disease: December 1998-July 2000
    Sarah L Lathrop
    Centers for Disease Control and Prevention, Epidemic Intelligence Service, Atlanta, GA 30333, USA
    Vaccine 20:1603-8. 2002
    ....
  48. ncbi Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events
    Alena Y Khromava
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 23:3256-63. 2005
    ..6-22.2). Yellow fever is a serious and potentially fatal disease. For elderly travelers, the risk for severe illness and death due to yellow fever infection should be balanced against the risk of a serious adverse event due to YEL...
  49. ncbi Hepatitis B vaccine and risk of multiple sclerosis
    Frank Destefano
    Pharmacoepidemiol Drug Saf 16:705-7, author reply 707-8. 2007
  50. ncbi Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study
    Michael L Jackson
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 16:790-6. 2007
    ..We sought to determine whether vaccinations are associated with changes in International Normalized Ratio (INR) in persons on long-term warfarin therapy...
  51. ncbi Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study
    Frank Destefano
    Neurology 64:1317; author reply 1317. 2005
  52. ncbi Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
    Eric K France
    Department of Preventive Medicine, Kaiser Pemanente Colorado, Denver, CO 80231, USA
    Pediatrics 121:e687-92. 2008
    ..The measles-mumps-rubella vaccine has been associated with immune thrombocytopenia purpura in 2 small studies...
  53. ncbi Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old
    Simon J Hambidge
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    JAMA 296:1990-7. 2006
    ..Beginning with the winter season of 2004-2005, influenza vaccination has been recommended for all children 6 to 23 months old in the United States. However, its safety in young children has not been adequately studied in large populations...
  54. ncbi Validation of a screening instrument to identify persons for exclusion from smallpox vaccination
    Edward A Belongia
    Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA
    Clin Infect Dis 40:620-3. 2005
    ..Further assessment of screening procedures is needed if the administration of smallpox vaccine becomes more widespread in the future...
  55. ncbi Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination
    Allison L Naleway
    Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA
    Ann Intern Med 139:1-7. 2003
    ....
  56. ncbi Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines
    Thomas Verstraeten
    GlaxoSmithKline Biologicals, Rixensart, Belgium
    Expert Rev Vaccines 2:21-9. 2003
    ..We also offer our opinion on the future use of large linked databases for vaccine safety surveillance purposes...
  57. ncbi Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001
    Weigong Zhou
    Epidemic Intelligence Service Program, Epidemiology Program Office, CDC, USA
    MMWR Surveill Summ 52:1-24. 2003
    ..This knowledge facilitates improvement in the safety of vaccines and the vaccination process...
  58. ncbi Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997
    Jenifer C Lloyd
    Office of Epidemiology, Utah Department of Health, Bureau for Children with Special Health Care Needs, P O Box 144640, Salt Lake City, UT 84114 4640, USA
    Vaccine 21:3746-50. 2003
    ..While reporting rates are lower after TT than Td, rates of reported VAEs after both vaccines are low...
  59. ncbi Polio extraimmunization in children younger than 2 years after changes in immunization recommendations
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 111:296-301. 2003
    ..CONCLUSIONS: Poliovirus extraimmunization rates have fallen dramatically in association with the change-over to the all inactivated polio virus schedule...
  60. ncbi The development of standardized case definitions and guidelines for adverse events following immunization
    Katrin S Kohl
    Vaccine 25:5671-4. 2007
  61. ncbi Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
    Margot Mutsch
    Division of Communicable Diseases, World Health Organization Collaborating Centre for Travellers Health, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    N Engl J Med 350:896-903. 2004
    ..After the introduction of an inactivated intranasal influenza vaccine that was used only in Switzerland, 46 cases of Bell's palsy were reported...
  62. ncbi Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
    Frederick Varricchio
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration/NIH/DHHS, Rockville MD, USA
    Pediatr Infect Dis J 23:287-94. 2004
    ..Confirmation in a controlled study is usually required. An understanding of the system's defined objectives and inherent drawbacks is vital to the effective use of VAERS data in vaccine safety investigations...
  63. ncbi Vaccine safety issues: introduction
    Robert T Chen
    Semin Pediatr Infect Dis 14:187. 2003
  64. ncbi Compliance with national immunization guidelines for children younger than 2 years, 1996-1999
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 115:461-7. 2005
    ..6% of children were compliant with prevailing childhood immunization recommendations from 1996 to 1999. Efforts to improve compliance with guidelines are recommended, to optimize childhood infectious disease prevention...
  65. ncbi Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases
    Ann W McMahon
    1401 Rockville Pike, HFM 220, Rockville, MD 20852, USA
    Vaccine 25:1727-34. 2007
    ..Laboratory and epidemiological evidence suggests that YEL caused encephalitis. Additional studies will be required to confirm whether YEL can rarely result in GBS and/or ADEM...
  66. ncbi Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project
    Eileen M Eriksen
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 23:656-62. 2004
    ..CONCLUSIONS: A relationship between HBV and neonatal death was not identified...
  67. ncbi Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome
    Irving Nachamkin
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 4283, USA
    J Infect Dis 198:226-33. 2008
    ....
  68. ncbi Standardized case definitions of adverse events following immunization (AEFI)
    Jan Bonhoeffer
    Vaccine 22:547-50. 2004